- Home
- HIHO vs SNGX Comparison
HIHO vs SNGX Comparison
Compare HIHO & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HIHO
- SNGX
- Stock Information
- Founded
- HIHO 1990
- SNGX 1987
- Country
- HIHO Hong Kong
- SNGX United States
- Employees
- HIHO N/A
- SNGX N/A
- Industry
- HIHO Industrial Machinery/Components
- SNGX Biotechnology: Pharmaceutical Preparations
- Sector
- HIHO Industrials
- SNGX Health Care
- Exchange
- HIHO Nasdaq
- SNGX Nasdaq
- Market Cap
- HIHO 8.2M
- SNGX 7.4M
- IPO Year
- HIHO 1996
- SNGX 1987
- Fundamental
- Price
- HIHO $1.88
- SNGX $2.39
- Analyst Decision
- HIHO
- SNGX
- Analyst Count
- HIHO 0
- SNGX 0
- Target Price
- HIHO N/A
- SNGX N/A
- AVG Volume (30 Days)
- HIHO 4.0K
- SNGX 44.9K
- Earning Date
- HIHO 01-21-2025
- SNGX 03-14-2025
- Dividend Yield
- HIHO 6.39%
- SNGX N/A
- EPS Growth
- HIHO N/A
- SNGX N/A
- EPS
- HIHO N/A
- SNGX N/A
- Revenue
- HIHO $7,345,000.00
- SNGX $364,183.00
- Revenue This Year
- HIHO N/A
- SNGX N/A
- Revenue Next Year
- HIHO N/A
- SNGX $76.64
- P/E Ratio
- HIHO N/A
- SNGX N/A
- Revenue Growth
- HIHO 11.36
- SNGX N/A
- 52 Week Low
- HIHO $1.70
- SNGX $1.83
- 52 Week High
- HIHO $2.88
- SNGX $14.88
- Technical
- Relative Strength Index (RSI)
- HIHO 48.27
- SNGX 43.83
- Support Level
- HIHO $1.83
- SNGX $2.25
- Resistance Level
- HIHO $1.94
- SNGX $2.60
- Average True Range (ATR)
- HIHO 0.04
- SNGX 0.15
- MACD
- HIHO 0.00
- SNGX 0.03
- Stochastic Oscillator
- HIHO 42.27
- SNGX 52.27
About HIHO Highway Holdings Limited
Highway Holdings Ltd is a holding company. The company is a manufacturer of metal, plastic, electric and electronic components for original equipment manufacturers (OEM) and contract manufacturers. Its operating segment includes Metal stamping and mechanical OEM and Electric OEM. The metal stamping segment focuses on the manufacturing and sale of metal parts and components. The company generates maximum revenue from the Metal stamping and mechanical OEM segment. Geographically, it derives a majority of its revenue from Europe and also has a presence in Hong Kong and China, North America, and Other Asian countries.
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).